Skip to main content
. 2022 Feb 1;14:20. doi: 10.1186/s13195-022-00967-z

Fig. 1.

Fig. 1

Distribution of participants according to CSF levels of Aβ1–42 and amyloid ratio within diagnostic categories. CN, cognitively normal; AD, Alzheimer’s disease; DLB, dementia with Lewy bodies; FTLD, frontotemporal lobar degeneration-related syndrome. Dashed lines indicate 95% quantile values (Q95%) for Aβ1–42 and Aβ1–42/Aβ1–40 in a middle-aged cognitively normal population as described in the “Material and methods” section